68Ga-labeled NY104 PET Imaging in Patients

Summary

This is a single arm study to evaluate the safety and biodistribution of 68Ga-labeled NY104 PET Imaging in patients with Renal Cell Carcinoma

Timeline

Start

2022-10-10

Primary completion

2023-10

Completion

2023-10

Publications

• Lou K, Wang J, He H, Wang Y, Mi Y, Li W, Chen L, Zhang Y, Mao Y, Lin J, Fu H, Yu C. Value of [68Ga]Ga-NYM046 PET/CT, in Comparison with 18F-FDG PET/CT, for Diagnosis of Clear Cell Renal Cell Carcinoma. J Nucl Med. 2024 Dec 3;65(12):1884-1890. doi: 10.2967/jnumed.124.267527.

Drugs

Indications